152 related articles for article (PubMed ID: 18246121)
1. Cyclin-dependent kinase antagonizes promyelocytic leukemia zinc-finger through phosphorylation.
Costoya JA; Hobbs RM; Pandolfi PP
Oncogene; 2008 Jun; 27(27):3789-96. PubMed ID: 18246121
[TBL] [Abstract][Full Text] [Related]
2. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A.
Yeyati PL; Shaknovich R; Boterashvili S; Li J; Ball HJ; Waxman S; Nason-Burchenal K; Dmitrovsky E; Zelent A; Licht JD
Oncogene; 1999 Jan; 18(4):925-34. PubMed ID: 10023668
[TBL] [Abstract][Full Text] [Related]
3. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
4. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF.
Chauchereau A; Mathieu M; de Saintignon J; Ferreira R; Pritchard LL; Mishal Z; Dejean A; Harel-Bellan A
Oncogene; 2004 Nov; 23(54):8777-84. PubMed ID: 15467736
[TBL] [Abstract][Full Text] [Related]
5. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
[TBL] [Abstract][Full Text] [Related]
6. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
7. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
[TBL] [Abstract][Full Text] [Related]
8. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis.
Rho SB; Park YG; Park K; Lee SH; Lee JH
FEBS Lett; 2006 Jul; 580(17):4073-80. PubMed ID: 16828757
[TBL] [Abstract][Full Text] [Related]
9. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.
Li JY; English MA; Ball HJ; Yeyati PL; Waxman S; Licht JD
J Biol Chem; 1997 Sep; 272(36):22447-55. PubMed ID: 9278395
[TBL] [Abstract][Full Text] [Related]
10. Role of promyelocytic leukemia zinc finger protein in proliferation of cultured human corneal endothelial cells.
Shiraishi A; Joko T; Higashiyama S; Ohashi Y
Cornea; 2007 Oct; 26(9 Suppl 1):S55-8. PubMed ID: 17881917
[TBL] [Abstract][Full Text] [Related]
11. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.
Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C
Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145
[TBL] [Abstract][Full Text] [Related]
12. The alpha subunit of Go interacts with promyelocytic leukemia zinc finger protein and modulates its functions.
Won JH; Park JS; Ju HH; Kim S; Suh-Kim H; Ghil SH
Cell Signal; 2008 May; 20(5):884-91. PubMed ID: 18262754
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by the BTB domain of promyelocytic leukemia zinc finger protein.
Rho SB; Choi K; Park K; Lee JH
Cancer Lett; 2010 Aug; 294(1):49-56. PubMed ID: 20236758
[TBL] [Abstract][Full Text] [Related]
14. SUMO modification modulates the transrepression activity of PLZF.
Chao TT; Chang CC; Shih HM
Biochem Biophys Res Commun; 2007 Jun; 358(2):475-82. PubMed ID: 17498654
[TBL] [Abstract][Full Text] [Related]
15. Role of promyelocytic leukemia zinc finger (PLZF) in cell proliferation and cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) gene repression.
Choi WI; Kim MY; Jeon BN; Koh DI; Yun CO; Li Y; Lee CE; Oh J; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18625-40. PubMed ID: 24821727
[TBL] [Abstract][Full Text] [Related]
16. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
[TBL] [Abstract][Full Text] [Related]
17. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
Kang SI; Chang WJ; Cho SG; Kim IY
J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.
Choi WI; Yoon JH; Kim MY; Koh DI; Licht JD; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18641-56. PubMed ID: 24821728
[TBL] [Abstract][Full Text] [Related]
19. The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase.
Ball HJ; Melnick A; Shaknovich R; Kohanski RA; Licht JD
Nucleic Acids Res; 1999 Oct; 27(20):4106-13. PubMed ID: 10497277
[TBL] [Abstract][Full Text] [Related]
20. Biallelic loss of function of the promyelocytic leukaemia zinc finger (PLZF) gene causes severe skeletal defects and genital hypoplasia.
Fischer S; Kohlhase J; Böhm D; Schweiger B; Hoffmann D; Heitmann M; Horsthemke B; Wieczorek D
J Med Genet; 2008 Nov; 45(11):731-7. PubMed ID: 18611983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
